China: Data Protection

China's revised Good Clinical Practice for Drug Trials took effect on 1 September 2026, fundamentally reshaping the regulatory landscape for clinical trials by aligning domestic requirements with ICH E6(R3) standards. The new framework introduces streamlined regulations spanning just 54 articles across six chapters, while establishing comprehensive data governance requirements and clarifying ultimate accountability for sponsors, principal investigators, and clinical trial institutions. Companies conducting

具身智能设备涉及机器人厂商、模型公司、云平台等多方协作,数据处理、模型调用和设备控制相互关联。企业如何在多主体生态中明确责任边界、

2026年6月18日，国家互联网信息办公室、工业和信息化部、公安部联合公布《网络数据安全风险评估办法》（以下简称“《办法》”），并将于2026年8月20日起施行。